Bruker Corp. Now Covered by Analysts at Maxim Group (BRKR)
Stock analysts at Maxim Group started coverage on shares of Bruker Corp. (NASDAQ:BRKR) in a report issued on Thursday, TheFlyOnTheWall.com reports. The firm set a “buy” rating on the stock.
Several other analysts have also recently commented on the stock. Analysts at Cleveland Research initiated coverage on shares of Bruker Corp. (NASDAQ:BRKR) in a research note to investors on Friday, September 20th. They set a “buy” rating on the stock. Separately, analysts at Wells Fargo & Co. downgraded shares of Bruker Corp. (NASDAQ:BRKR) from an “outperform” rating to a “market perform” rating in a research note to investors on Friday, September 20th. They noted that the move was a valuation call. Finally, analysts at Mizuho raised their price target on shares of Bruker Corp. (NASDAQ:BRKR) from $21.00 to $25.00 in a research note to investors on Friday, August 23rd. They now have a “buy” rating on the stock. Five investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Bruker Corp. currently has an average rating of “Buy” and a consensus price target of $22.23.
Shares of Bruker Corp. (NASDAQ:BRKR) traded up 1.20% during mid-day trading on Thursday, hitting $20.29. The stock had a trading volume of 402,705 shares. Bruker Corp. has a one year low of $11.58 and a one year high of $21.11. The stock’s 50-day moving average is $20.16 and its 200-day moving average is $18.21. The company has a market cap of $3.384 billion and a P/E ratio of 41.86.
Bruker Corp. (NASDAQ:BRKR) last released its earnings data on Wednesday, July 31st. The company reported $0.18 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.14 by $0.04. The company had revenue of $454.90 million for the quarter, compared to the consensus estimate of $426.39 million. During the same quarter in the prior year, the company posted $0.12 earnings per share. The company’s quarterly revenue was up 8.1% on a year-over-year basis. On average, analysts predict that Bruker Corp. will post $0.82 earnings per share for the current fiscal year.
Bruker Corporation (NASDAQ:BRKR) is a global manufacturer of scientific instruments that address the rapidly evolving needs of a diverse array of customers in life science, pharmaceutical, biotechnology, clinical and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.